Antibody-Drug Conjugate Targets
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
982-1004
Author(s):
B. A. Teicher
Dendritic Cells for Active Anti-Cancer Immunotherapy: Targeting Activation Pathways Through Genetic Modification
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
9
Page:
328-343
Author(s):
Karine Breckpot and David Escors
The Potential use of Dendritic Cell-based Immunotherapy for Treatment of Pancreatic Cancer
Journal:
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume:
9
Page:
191-202
Author(s):
Mohamed Labib Salem
Aging and Inflammation: Etiological Culprits of Cancer
Journal:
Current Aging Science
Volume:
2
Page:
174-186
Author(s):
Aamir Ahmad, Sanjeev Banerjee, Zhiwei Wang, Dejuan Kong, Adhip P.N. Majumdar and Fazlul H. Sarkar
In Search for the Troponin of the Kidney
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
4219-4229
Author(s):
S-J. Noppert and G. Mayer
The Structure and Pharmacological Functions of Coumarins and Their Derivatives
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
4236-4260
Author(s):
L. Wu, X. Wang, W. Xu, F. Farzaneh and R. Xu
HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
3839-3843
Author(s):
G. L. Semenza
Regulation of HIF-1α at the Transcriptional Level
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
3844-3852
Author(s):
Agnes Gorlach
HIF Prolyl-4-hydroxylase Interacting Proteins: Consequences for Drug Targeting
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
3886-3894
Author(s):
Roland H. Wenger, Gieri Camenisch, Daniel P. Stiehl and Dorthe M. Katschinski
The VHL Tumor Suppressor: Master Regulator of HIF
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
3895-3903
Author(s):
Volker H. Haase